Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. May 27, 2014; 6(5): 306-314
Published online May 27, 2014. doi: 10.4254/wjh.v6.i5.306
Published online May 27, 2014. doi: 10.4254/wjh.v6.i5.306
Criteria | Consensual criteria definition1 | Other non-consensual criteria |
Central obesity | Abdominal waist2 | Different cutoff values of BMI ≥ 28 or ≥ 28.8 or ≥ 30 kg/m2 |
> 102 cm (United States) or 94 cm (Europe) in men | ||
> 88 cm (United States) or 80 cm (Europe) in women | ||
Dyslipidemia | Triglycerides ≥ 150 mg/dL (1.7 mmol/L) | Statin or fenofibrate medication3 |
HDL cholesterol | ||
< 40 mg/dL (1.03 mmol/L) in men | ||
< 50 mg/dL (1.29 mmol/L) in women | ||
Hypertension | Blood pressure > 135/85 mmHg | Any antihypertensive therapy3 |
Glucose intolerance | Hyperglycemia | Any diabetes Any antidiabetic therapy (oral or insulin) |
Fasting glucose ≥ 110 mg/dL, | ||
or type II diabetes |
Ref. | Endpoint | Underlying parenchyma | Assessment of metabolic factors | Morbidity | Mortality | ||
Overall | Liver related | CV and respiratory | |||||
Wakai et al[9] | Influence of the underlying liver on liver resection | NAFLD (n = 17) | BMI | 59% | 47% | 6% | 12% |
Neal et al[10] | Influence of the underlying liver on right trisectionectomy | NASH (n = 9) | All factors | NA | NA | NA | 22% |
Reddy et al[11] | Influence of the underlying liver on liver resection | Simple steatosis (n = 72) | All factors | 35% | 19% | 28% | 4% |
NASH (n = 102) | 57% | 28% | 13% | 4% | |||
Bhayani et al[12] | Influence of the MS on liver resection | NA | MS (n = 256) | 29% | NA | 22% | 6% |
No MS (n = 3.717) | 23% | 15% | 2% | ||||
Zarzavadjian Le Bian et al[13] | Influence of the MS on right trisectionectomy | NAFLD (n = 27) | > 2 MS factors (n = 30) | 60% | 53% | NA | 30% |
≥ 3 MS factors (n = 13) | NA | NA | NA | 54% | |||
Cauchy et al[8] | Influence of the MS on liver resection | NASH (n = 16) | MS (n = 62) | 58% | 21%1 | 17%1 | 11% |
- Citation: Cauchy F, Fuks D, Zarzavadjian Le Bian A, Belghiti J, Costi R. Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges? World J Hepatol 2014; 6(5): 306-314
- URL: https://www.wjgnet.com/1948-5182/full/v6/i5/306.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i5.306